JP2019509329A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509329A5
JP2019509329A5 JP2018556016A JP2018556016A JP2019509329A5 JP 2019509329 A5 JP2019509329 A5 JP 2019509329A5 JP 2018556016 A JP2018556016 A JP 2018556016A JP 2018556016 A JP2018556016 A JP 2018556016A JP 2019509329 A5 JP2019509329 A5 JP 2019509329A5
Authority
JP
Japan
Prior art keywords
administered
oncos
adenovirus
malignant mesothelioma
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018556016A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019509329A (ja
JP6974350B2 (ja
Filing date
Publication date
Priority claimed from FI20165026A external-priority patent/FI127460B/en
Application filed filed Critical
Publication of JP2019509329A publication Critical patent/JP2019509329A/ja
Publication of JP2019509329A5 publication Critical patent/JP2019509329A5/ja
Priority to JP2021180012A priority Critical patent/JP2022023978A/ja
Application granted granted Critical
Publication of JP6974350B2 publication Critical patent/JP6974350B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018556016A 2016-01-15 2017-01-11 がんを治療するためのアデノウイルス及び化学療法剤の組合せ Expired - Fee Related JP6974350B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021180012A JP2022023978A (ja) 2016-01-15 2021-11-04 がんを治療するためのアデノウイルス及び化学療法剤の組合せ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20165026A FI127460B (en) 2016-01-15 2016-01-15 Combining adenovirus and chemotherapeutic agents for treating cancer
FI20165026 2016-01-15
PCT/FI2017/050010 WO2017121925A1 (en) 2016-01-15 2017-01-11 Combining adenovirus and chemotherapeutic agents for treating cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021180012A Division JP2022023978A (ja) 2016-01-15 2021-11-04 がんを治療するためのアデノウイルス及び化学療法剤の組合せ

Publications (3)

Publication Number Publication Date
JP2019509329A JP2019509329A (ja) 2019-04-04
JP2019509329A5 true JP2019509329A5 (cg-RX-API-DMAC7.html) 2020-02-20
JP6974350B2 JP6974350B2 (ja) 2021-12-01

Family

ID=57909646

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018556016A Expired - Fee Related JP6974350B2 (ja) 2016-01-15 2017-01-11 がんを治療するためのアデノウイルス及び化学療法剤の組合せ
JP2021180012A Pending JP2022023978A (ja) 2016-01-15 2021-11-04 がんを治療するためのアデノウイルス及び化学療法剤の組合せ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021180012A Pending JP2022023978A (ja) 2016-01-15 2021-11-04 がんを治療するためのアデノウイルス及び化学療法剤の組合せ

Country Status (8)

Country Link
US (1) US20190000898A1 (cg-RX-API-DMAC7.html)
EP (2) EP3402889B1 (cg-RX-API-DMAC7.html)
JP (2) JP6974350B2 (cg-RX-API-DMAC7.html)
CN (2) CN108495934B (cg-RX-API-DMAC7.html)
ES (1) ES2904611T3 (cg-RX-API-DMAC7.html)
FI (1) FI127460B (cg-RX-API-DMAC7.html)
PL (1) PL3402889T3 (cg-RX-API-DMAC7.html)
WO (1) WO2017121925A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018182014A1 (ja) * 2017-03-31 2018-10-04 久修 緒方 腫瘍溶解性ウイルスの増殖方法及び抗腫瘍剤
WO2019048689A1 (en) 2017-09-11 2019-03-14 Imba - Institut Für Molekulare Biotechnologie Gmbh TUMOR ORGANOID MODEL

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010006633A1 (en) 1998-05-15 2001-07-05 David Kirn Adenovirus-chemotherapeutic combination for treating cancer
US6511676B1 (en) 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
SV2006002143A (es) * 2004-06-16 2006-01-26 Genentech Inc Uso de un anticuerpo para el tratamiento del cancer resistente al platino
CN101878229A (zh) * 2007-09-28 2010-11-03 巴塞尔大学医院 用于治疗癌症的免疫脂质体
WO2009044153A2 (en) * 2007-10-03 2009-04-09 Cancer Research Technology Limited Inhibitors and uses
CN101411710B (zh) * 2008-11-25 2011-06-15 江苏奥赛康药业有限公司 培美曲塞二钠冻干粉针剂及其制备方法
BRPI0924123B8 (pt) * 2008-12-22 2021-05-25 Oncos Therapeutics Oy vetores adenovirais oncolíticos, usos dos mesmos, composição farmacêutica e método para produzir gmcsf em uma célula in vitro
WO2012122645A1 (en) * 2011-03-11 2012-09-20 Sarissa Inc. Methods of treating cancer by inhibition of dna repair proteins
US10238698B2 (en) * 2012-01-25 2019-03-26 Dnatrix, Inc. Biomarkers and combination therapies using oncolytic virus and immunomodulation
WO2013116778A2 (en) * 2012-02-02 2013-08-08 Board Of Regents Immunogenic adenovirus
KR101989171B1 (ko) * 2012-10-17 2019-06-14 바스큘라 바이오제닉스 리미티드 아데노바이러스를 사용하는 치료 방법

Similar Documents

Publication Publication Date Title
ES2964764T3 (es) Combinación terapéutica que comprende un inhibidor de cdk y oxaliplatino
JP2019206593A5 (cg-RX-API-DMAC7.html)
JP2020509024A5 (cg-RX-API-DMAC7.html)
JP2020523356A5 (cg-RX-API-DMAC7.html)
JP2019536805A5 (cg-RX-API-DMAC7.html)
JP2012506448A5 (cg-RX-API-DMAC7.html)
JP2014148535A5 (cg-RX-API-DMAC7.html)
JP2014040437A5 (cg-RX-API-DMAC7.html)
NZ708506A (en) Methods of treating bladder cancer
JP2016515586A5 (cg-RX-API-DMAC7.html)
JP2020523354A5 (cg-RX-API-DMAC7.html)
HRP20171216T1 (hr) Pripravak koji sadrži aflibercept, folinsku kiselinu, 5-fluorouracil (5-fu) i irinotekan (folfiri)
JP2017506624A5 (cg-RX-API-DMAC7.html)
JP2016510326A5 (cg-RX-API-DMAC7.html)
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
JP2020523359A5 (cg-RX-API-DMAC7.html)
AR079174A1 (es) Composiciones para comprimidos desintegrables oralmente de ondansetron para prevenir nauseas y vomitos
MX2022012351A (es) Administracion conjunta de mirdametinib y lifirafenib para uso en el tratamiento de canceres.
Gedlicka et al. Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
JP2008514577A5 (cg-RX-API-DMAC7.html)
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
JP2019526559A5 (cg-RX-API-DMAC7.html)
JP2017514854A5 (cg-RX-API-DMAC7.html)
JP2014504636A5 (cg-RX-API-DMAC7.html)
RU2018107930A (ru) Агонисты tlr4, их композиции и применение для лечения рака